nefrНефрологияNephrology (Saint-Petersburg)1561-62742541-9439Pavlov First Saint-Petersburg State Medical University10.24884/1561-6274-2012-16-2-64-68nefr-580Research ArticleОБЗОРЫ И ЛЕКЦИИREVIEWS AND LECTURESИНТРАДИАЛИЗНАЯ ГИПОТОНИЯ: ФАКТОРЫ, АССОЦИИРОВАННЫЕ С ПРОЦЕДУРОЙ ГЕМОДИАЛИЗАINTRADIALYSIS HYPOTENSION: FACTORS RELATED TO HEMODIALYSIS PROCEDUREШишкинА. Н.ShishkinA. N.

Кафедра факультетской терапии, медицинский факультет

199106, Санкт-Петербург, В.О., 21-я линия, д.8а. Тел.: 8 (812) 326-03-26

alexshishkin@bk.ruФедороваЮ. Ю.FedorovaY. Y.

Кафедра факультетской терапии, медицинский факультет

Санкт-Петербургский государственный университетRussian Federation2012100220121626468Copyright © Шишкин А.Н., Федорова Ю.Ю., 20122012Шишкин А.Н., Федорова Ю.Ю.Shishkin A.N., Fedorova Y.Y.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://journal.nephrolog.ru/jour/article/view/580

Одним из наиболее часто встречающихся осложнений процедуры гемодиализа является интрадиализная гипотония (ИДГ), распространенность которой составляет от 10–50%. В обзоре приведены сведения о причинах ИДГ, ассоциированных с процедурой гемодиализа.

Intradialysis hypotension (IDH) is one of the most common complications in hemodialysis procedure, its occurrence is 10-50%. In this review information about the causes of IDH associated with dialysis procedure is given.

интрадиализная гипотониягемодиализхроническая почечная недостаточностьintradialysis hypotensionhemodialysischronic kidney failureReferencesСуворов АВ, Зубеева ГН, Суслова ОА и др. Особенности артериальной гипертензии у пациентов с терминальной хронической почечной недостаточностью в додиализном и диализном периодах. Мед альманах 2010; 4: 249–251Суворов АВ, Зубеева ГН, Суслова ОА и др. Особенности артериальной гипертензии у пациентов с терминальной хронической почечной недостаточностью в додиализном и диализном периодах. Мед альманах 2010; 4: 249–251Хорошилов СЕ, Никитин АВ, Очеченко ТЮ. Опыт лечения тяжелых нарушений фосфорно-кальциевого обмена при терминальной почечной недостаточности с использованием цинакалцета. Леч Врач 2010; 1: 69–74Хорошилов СЕ, Никитин АВ, Очеченко ТЮ. Опыт лечения тяжелых нарушений фосфорно-кальциевого обмена при терминальной почечной недостаточности с использованием цинакалцета. Леч Врач 2010; 1: 69–74Бикбов БТ, Томилина НА. Состояние заместительной терапии больных с хронической почечной недостаточностью в Российской Федерации в 1998-2007 гг. (Аналитический отчет по данным Российского регистра заместительной почечной терапии). Нефрология и диализ 2009; 3: 144–233Бикбов БТ, Томилина НА. Состояние заместительной терапии больных с хронической почечной недостаточностью в Российской Федерации в 1998-2007 гг. (Аналитический отчет по данным Российского регистра заместительной почечной терапии). Нефрология и диализ 2009; 3: 144–233Чупрасов ВБ. Программный гемодиализ. Фолиант, СПб., 2001; 256Чупрасов ВБ. Программный гемодиализ. Фолиант, СПб., 2001; 256Kooman J, Basci A, Pizzarelli F et al. EBPG guidline on haemodynamic instability. Nephrol Dial Transplant 2007; 22(2): 22–44Kooman J, Basci A, Pizzarelli F et al. EBPG guidline on haemodynamic instability. Nephrol Dial Transplant 2007; 22(2): 22–44Venkat A, Kaufmann K, Venkat KK. Care of end-stage renal disease patient on dialysis in the ED. Am J Emerg Med 2006; 24(7): 847–858Venkat A, Kaufmann K, Venkat KK. Care of end-stage renal disease patient on dialysis in the ED. Am J Emerg Med 2006; 24(7): 847–858Booth J, Pinney J, Davenport A. The effect of vascular access modality on changes in fluid content in the arms as determined by multifrequency bioimpedance. Nephrol Dial Transplant 2011; 26(1): 227–231Booth J, Pinney J, Davenport A. The effect of vascular access modality on changes in fluid content in the arms as determined by multifrequency bioimpedance. Nephrol Dial Transplant 2011; 26(1): 227–231Imai E, Fujii M, Kohno Y et al. Adenosine A1 receptor antagonist improves intradialytic hypotension. Kidney Int 2006; 69(5): 877–883Imai E, Fujii M, Kohno Y et al. Adenosine A1 receptor antagonist improves intradialytic hypotension. Kidney Int 2006; 69(5): 877–883Chang TI, Paik J, Greene T et al. Intradialytic hypotension and vascular access thrombosis. J Am Soc Nephrol 2011; 22(8): 1526–1533Chang TI, Paik J, Greene T et al. Intradialytic hypotension and vascular access thrombosis. J Am Soc Nephrol 2011; 22(8): 1526–1533Shoji T, Tsubakihara Y, Fujii M et al. Hemodialysis-associated hypotension as an independent risk factor for two-year mortality in hemodialysis patients. Kidney Int 2004; 66(3): 1212–1220Shoji T, Tsubakihara Y, Fujii M et al. Hemodialysis-associated hypotension as an independent risk factor for two-year mortality in hemodialysis patients. Kidney Int 2004; 66(3): 1212–1220Tisler A, Akocsi K, Fazakas L et al. The effect of frequent or occasional dialysis-associated hypotension on survival of patients on maintenance haemodialysis. Nephrol Dial Transplant 2003; 18(12): 2601–2605Tisler A, Akocsi K, Fazakas L et al. The effect of frequent or occasional dialysis-associated hypotension on survival of patients on maintenance haemodialysis. Nephrol Dial Transplant 2003; 18(12): 2601–2605Mizumasa T, Hirakata H, Yoshimitsu T et al. Dialysis-related hypotension as a cause of progressive frontal lobe atrophy in chronic hemodialysis patients: A 3-year prospective study. Nepron Clin Pract 2004; 97(1): 23–30Mizumasa T, Hirakata H, Yoshimitsu T et al. Dialysis-related hypotension as a cause of progressive frontal lobe atrophy in chronic hemodialysis patients: A 3-year prospective study. Nepron Clin Pract 2004; 97(1): 23–30Chesterton LJ, Selby NM, Burton OJ et al. Cool dialysate reduces asymptomatic intradialytic hypotension and increases baroreflex variability. Hemodial Int 2009; 13(2): 189–196Chesterton LJ, Selby NM, Burton OJ et al. Cool dialysate reduces asymptomatic intradialytic hypotension and increases baroreflex variability. Hemodial Int 2009; 13(2): 189–196van der Sande FM, Wystrychowski G, Kooman JP et al. Control of core temperature and blood pressure stability during hemodialysis. Clin Am Soc Nephrol 2009; 4(1): 93–98van der Sande FM, Wystrychowski G, Kooman JP et al. Control of core temperature and blood pressure stability during hemodialysis. Clin Am Soc Nephrol 2009; 4(1): 93–98Korkor AB, Bretzmann CM, Eastwood DE. Effect of dialysate temperature on intradialytic hypotension. Dial Transplant 2010; 39(9): 377–385Korkor AB, Bretzmann CM, Eastwood DE. Effect of dialysate temperature on intradialytic hypotension. Dial Transplant 2010; 39(9): 377–385Selby NM, McIntyre CW. A systematic review of the clinical effects of reducing dialysate fluid temperature. Nephrol Dial Transplant 2006; 21(7): 1883–1898Selby NM, McIntyre CW. A systematic review of the clinical effects of reducing dialysate fluid temperature. Nephrol Dial Transplant 2006; 21(7): 1883–1898Palmer BF. Can chronic volume overload be recognized and prevented in hemodialysis patients? Semin Dial 2009; 22(5): 489–491Palmer BF. Can chronic volume overload be recognized and prevented in hemodialysis patients? Semin Dial 2009; 22(5): 489–491Maggiore Q. Isothermic dialysis for hypotension-prone patients. Semin Dial 2002; 15(3): 187–190Maggiore Q. Isothermic dialysis for hypotension-prone patients. Semin Dial 2002; 15(3): 187–190Naveed N, Masani N, Miyawaki N et al. A patient with uncommon etiology of intradialytic hypotension. Semin Dial 2005; 18(5): 435–439Naveed N, Masani N, Miyawaki N et al. A patient with uncommon etiology of intradialytic hypotension. Semin Dial 2005; 18(5): 435–439Mansell MA, Wing AJ. Acetate or bicarbonate for hemodialysis? Br Med J 1983; 287(6388): 308–309Mansell MA, Wing AJ. Acetate or bicarbonate for hemodialysis? Br Med J 1983; 287(6388): 308–309Ледебо И. Ацетатный и бикарбонатный диализ. Пер. с англ. С.В Лашутина, ИВ Дьяченко. Веселые картинки, М., 1999; 52–60Ледебо И. Ацетатный и бикарбонатный диализ. Пер. с англ. С.В Лашутина, ИВ Дьяченко. Веселые картинки, М., 1999; 52–60Иванова ЛН Физиологические механизмы регуляции водно-солевого баланса у животных и человека. Сорос Образ Журн 1996; (10): 4–12Иванова ЛН Физиологические механизмы регуляции водно-солевого баланса у животных и человека. Сорос Образ Журн 1996; (10): 4–12Palmer BF. Dialysis composition in hemodialysis and peritoneal dialysis. In: Henrich WL, eds. Principles and practice of dialysis, 4th ed. Lippincott Williams & Wilkins, Philadelphia, 2009; 25–41Palmer BF. Dialysis composition in hemodialysis and peritoneal dialysis. In: Henrich WL, eds. Principles and practice of dialysis, 4th ed. Lippincott Williams & Wilkins, Philadelphia, 2009; 25–41Стецюк ЕА. Натрий в диализате. В: Стецюк ЕА, Лашутин СВ, Чупрасов ВБ, ред. Диализный альманах. Элби-СПб, СПб., 2005; 100–106Стецюк ЕА. Натрий в диализате. В: Стецюк ЕА, Лашутин СВ, Чупрасов ВБ, ред. Диализный альманах. Элби-СПб, СПб., 2005; 100–106Gabutti L, Salvade I, Lucchini B et al. Haemodynamic consequences of changing potassium concentration in haemodialysis fluids. BMC Nephrol 2011; 12:14Gabutti L, Salvade I, Lucchini B et al. Haemodynamic consequences of changing potassium concentration in haemodialysis fluids. BMC Nephrol 2011; 12:14Dolson GM, Ellis KJ, Bernardo MV et al. Acute decreases in serum potassium augment blood pressure. Am J Kidney Dis 1995; 26: 321–326Dolson GM, Ellis KJ, Bernardo MV et al. Acute decreases in serum potassium augment blood pressure. Am J Kidney Dis 1995; 26: 321–326Locatalli F, Covic A, Chazot C et al. Optimal composition of the dialysate, with emphasis on its influence on blood pressure. Nephrol Dial Transplant 2004; 19(4): 785–796Locatalli F, Covic A, Chazot C et al. Optimal composition of the dialysate, with emphasis on its influence on blood pressure. Nephrol Dial Transplant 2004; 19(4): 785–796Николаев АЮ, Милованов ЮС. Лечение почечной недостаточности. Руководство для врачей. Медицинское информационное агентство, М., 1999; 242–269Николаев АЮ, Милованов ЮС. Лечение почечной недостаточности. Руководство для врачей. Медицинское информационное агентство, М., 1999; 242–269Phillipps LM, Harris DC. Review: modeling the dialysate. Nephrology (Carlton) 2010; 15(4): 393–398Phillipps LM, Harris DC. Review: modeling the dialysate. Nephrology (Carlton) 2010; 15(4): 393–398Bleyer AJ. Prevention of sudden cardiac death in dialysis patients: a nephrologist’s perspective. Dial Transplant 2008; 37(4): 124–129Bleyer AJ. Prevention of sudden cardiac death in dialysis patients: a nephrologist’s perspective. Dial Transplant 2008; 37(4): 124–129Kyriazis J, Glotsos J, Bilirakis L et al. Dialysate calcium profiling during hemodialysis: Use an clinical implications. Kidney Int 2002; 61(1): 276–287Kyriazis J, Glotsos J, Bilirakis L et al. Dialysate calcium profiling during hemodialysis: Use an clinical implications. Kidney Int 2002; 61(1): 276–287Kyriazis J, Katsipi I, Stylianou K et al. Arterial stiffness alterations during hemodialysis: the role of dialysate calcium. Nepron Clin Pract 2007; 106(1): 34–42Kyriazis J, Katsipi I, Stylianou K et al. Arterial stiffness alterations during hemodialysis: the role of dialysate calcium. Nepron Clin Pract 2007; 106(1): 34–42Elsharkawy MM, Youssef AM, Zayoon MY. Intradialytic changes of serum magnesium and their relation to hypotensive episodes in hemodialysis patients on different dialysates. Hemodial Int 2006; 10(2): 16–23Elsharkawy MM, Youssef AM, Zayoon MY. Intradialytic changes of serum magnesium and their relation to hypotensive episodes in hemodialysis patients on different dialysates. Hemodial Int 2006; 10(2): 16–23Pakfetrat M, Roozbeh Shahroodi J, Malekmakan L et al. Is there an association between intradialytic hypotension and serum magnesium changes? Hemodial Int 2010; 14(4): 492–497Pakfetrat M, Roozbeh Shahroodi J, Malekmakan L et al. Is there an association between intradialytic hypotension and serum magnesium changes? Hemodial Int 2010; 14(4): 492–497Kyriazis J, Kalogeropoulou K, Bilirakis L et al. Dialysate magnesium level and blood pressure. Kidney Int 2004; 66(3): 1221–1231Kyriazis J, Kalogeropoulou K, Bilirakis L et al. Dialysate magnesium level and blood pressure. Kidney Int 2004; 66(3): 1221–1231Stegmayr BG. Ultrafiltration and dry weight – what are the cardiovascular effects? Artif Organs 2003; 27(3): 227–229Stegmayr BG. Ultrafiltration and dry weight – what are the cardiovascular effects? Artif Organs 2003; 27(3): 227–229Costanzo MR. The role of ultrafiltration in the management of heart failure. Curr Treat Options Cardiovasc Med 2006; 8(4): 301–309Costanzo MR. The role of ultrafiltration in the management of heart failure. Curr Treat Options Cardiovasc Med 2006; 8(4): 301–309Suhail A. Manual of clinical dialysis, 2nd ed. Springer, New York, 2009; 59–68Suhail A. Manual of clinical dialysis, 2nd ed. Springer, New York, 2009; 59–68Showkat A, Acchiardo SA, Owen WF. Dialysis therapy in the intensive care settings. In: Irwin RS, Ripple JM, eds. Irwin and Ripple’s intensive care medicine, 6th ed. Lippincott Williams & Wilkins, Philadelphia, 2007; 232–257Showkat A, Acchiardo SA, Owen WF. Dialysis therapy in the intensive care settings. In: Irwin RS, Ripple JM, eds. Irwin and Ripple’s intensive care medicine, 6th ed. Lippincott Williams & Wilkins, Philadelphia, 2007; 232–257Song JH, Park GH, Lee SY et al. Effect of sodium balance and the combination of ultrafiltration profile during sodium profiling hemodialysis on the maintence of the quality of dialysis and sodium and fluid balances. J Am Soc Nephrol 2005; 16(1): 237–246Song JH, Park GH, Lee SY et al. Effect of sodium balance and the combination of ultrafiltration profile during sodium profiling hemodialysis on the maintence of the quality of dialysis and sodium and fluid balances. J Am Soc Nephrol 2005; 16(1): 237–246Al-Hilali N, Al-Humoud HM, Ninan VT et al. Profiled hemodialysis reduces intradialytic symptoms. Transpl Proceed 2004; 36: 1827–1828Al-Hilali N, Al-Humoud HM, Ninan VT et al. Profiled hemodialysis reduces intradialytic symptoms. Transpl Proceed 2004; 36: 1827–1828Oliver MJ, Edwards LJ, Churchill DN. Impact of sodium and ultrafiltration profiling on hemodialysis-related symptoms. J Am Soc Nephrol 2001; 12(1): 151–156Oliver MJ, Edwards LJ, Churchill DN. Impact of sodium and ultrafiltration profiling on hemodialysis-related symptoms. J Am Soc Nephrol 2001; 12(1): 151–156Zhou YL, Liu HL, Duan XF et al. Impact of sodium and ultrafiltration profiling on hemodialysis-related hypotension. Nephrol Dial Transplant 2006; 21(11): 3231–3237Zhou YL, Liu HL, Duan XF et al. Impact of sodium and ultrafiltration profiling on hemodialysis-related hypotension. Nephrol Dial Transplant 2006; 21(11): 3231–3237Стецюк ЕА. Теория гемодиализа. В: Мазо ЕБ, ред. Основы гемодиализа. Гэотар-Мед, М., 2001; 4–21Стецюк ЕА. Теория гемодиализа. В: Мазо ЕБ, ред. Основы гемодиализа. Гэотар-Мед, М., 2001; 4–21Строков АГ, Терехов ВА. Показатель относительного объема крови у пациентов на программном гемодиализе. Нефрология и диализ 2010; 2: 101–105Строков АГ, Терехов ВА. Показатель относительного объема крови у пациентов на программном гемодиализе. Нефрология и диализ 2010; 2: 101–105Строков АГ, Терехов ВА, Гаврилин ВА и др. Интрадиализная артериальная гипотензия и ее профилактика при помощи мониторинга относительного объема крови. Нефрология и диализ 2010; 4: 250–254Строков АГ, Терехов ВА, Гаврилин ВА и др. Интрадиализная артериальная гипотензия и ее профилактика при помощи мониторинга относительного объема крови. Нефрология и диализ 2010; 4: 250–254Терехов ВА, Строков АГ. Показатель относительного объема крови как средство профилактики артериальной гипотензии в ходе гемодиализа. Вестн трансплантологии и искусственных органов 2010; 3: 101–105Терехов ВА, Строков АГ. Показатель относительного объема крови как средство профилактики артериальной гипотензии в ходе гемодиализа. Вестн трансплантологии и искусственных органов 2010; 3: 101–105Santorio A, Mancini E, Basile C et al. Blood volume controlled hemodialysis in hypotension-prone patients: A randomized, multicenter controlled trial. Kidney Int 2002; 62: 1034–1045Santorio A, Mancini E, Basile C et al. Blood volume controlled hemodialysis in hypotension-prone patients: A randomized, multicenter controlled trial. Kidney Int 2002; 62: 1034–1045Gabrielli D, Kristal B, Katzarski K et al. Improved intradialytic stability during haemodialysis with blood volume-controlled ultrafiltration. J Nephrol 2009; 22(2): 232–240Gabrielli D, Kristal B, Katzarski K et al. Improved intradialytic stability during haemodialysis with blood volume-controlled ultrafiltration. J Nephrol 2009; 22(2): 232–240Lee P-T, Fang H-C, Chen C-L et al. High vibration perception threshold and autonomic dysfunction in hemodialysis patients with intradialytic hypotension. Kidney Int 2003; 64: 1089–1094Lee P-T, Fang H-C, Chen C-L et al. High vibration perception threshold and autonomic dysfunction in hemodialysis patients with intradialytic hypotension. Kidney Int 2003; 64: 1089–1094Raimann J, Liu L, Tyagi S еt al. A fresh look at dry weight. Hemodial Int 2008; 12: 395–405Raimann J, Liu L, Tyagi S еt al. A fresh look at dry weight. Hemodial Int 2008; 12: 395–405

The authors declare that there are no conflicts of interest present.